Latest News
FTSE 250 movers: Travel issues drag on second-tier index, Cineworld gains
Travel-related issues were at the bottom of the pile on the second-tier index on Monday, as governments around the world, including the US and UK, moved to tighten restrictions on foreigners arriving from virus hot spots.
US close: Stocks mixed ahead of major corporate earnings
Wall Street stocks turned in a mixed performance on Monday ahead of some key corporate earnings later in the week.
Reckitt Benckiser withdraws $1.4bn claim against Indivior
Indivior has reached a settlement with Reckitt Benckiser regarding the latter's claims against derived from its 2019 settlement with the US Department of Justice and Federal Trade Commission.
Tuesday preview: UK employment, Distributive Trades Index in focus
Financial markets' focus on Tuesday will be on the latest UK employment.
Sector movers: Concerns around Covid vaccine rollouts drag on sentiment
News of setbacks for the expected pace of Covid-19 vaccinations, particularly on the Continent, but also further afield, potentially including in the likes of Australia, Canada and Thailand weighed on investor sentiment.
Europe close: Value stocks fall back amid bad news for Covvid-19 vaccine rollouts
European shares fell back at the start of the week with investors scurrying back towards tech stocks as the prospect of extended Covid lockdowns on the Continent battered travel and leisure companies.
Low-skilled workers, carers and service staff three times more likely to die from Covid-19 - ONS
The Office for National Statistics published a report on Covid deaths in 2020 by occupation on Monday which revealed that men working in low-skilled jobs in the care sector or in other service jobs were most at risk.
Italian PM Conte set to step down on Tuesday
Italy's Prime Minister is set to step down on Tuesday.
Blackberry unaware of reasons behind surge in company's share price
Blackberry said it was not aware of any "material, undisclosed corporate developments" that might explain Monday's rapid climb in its stock price.
Boeing 737 Max flight approval in Europe angers crash victims' relatives
A green light from the European Union to lift a 22-month flight ban on the Boeing 737 MAX this week has angered relatives of 346 victims of two crashes involving the jet.
City centre rents hit hard as tenants move to suburbs
City centres in the UK are suffering from falling rents as tenants increasingly decide to move to the suburbs due to the pandemic.
London close: Stocks finish weaker as travel plays take hit
London stocks closed in negative territory on Monday, with travel and leisure stocks under the cosh as the prospect of tighter border restrictions and a prolonged lockdown weighed on sentiment.
Kefi makes good progress in Ethiopia, Saudi Arabia
Gold exploration and development company Kefi Gold and Copper updated the market on operations in Ethiopia and Saudi Arabia in its fourth quarter on Monday, reporting that financing for the Tulu Kapi Gold Project in Ethiopia remained on track.
Broker tips: Synthomer, Evraz
Analysts at Berenberg raised their target price on chemicals group Synthomer from 430. 0p to 515. 0p on Monday, stating continued upgrades from nitrile latex provided "an auspicious backdrop" for 2021.
Director dealings: AFH Financial CEO makes share sale
AFH Financial Group said on Monday that chief executive Alan Hudson had disposed of 4. 29m ordinary shares in the AIM-listed wealth management firm.
Amigo warns on insolvency if payout plan fails
Amigo said it would be insolvent if a proposed cap on customer payouts fails as the subprime lender published details of its plan.
FTSE 100 movers: Travel & leisure shares drop; dollar-earners rise
London’s FTSE 100 was down 1% at 6,629. 47 in afternoon trade on Monday.
Panthera continues work on West Africa programmes
Diversified gold exploration and development company Panthera Resources updated the market on its West Africa exploration programmes on Monday, as well as the projects owned by its associated company Moydow Holdings.
Johnson and Johnson Covid-19 vaccine may approved in two weeks
Johnson&Johnson's Covid-19 vaccine may be two weeks from approval, one of the top US health officials said.
Dominion sues Trump lawyer Giuliani for $1.3bn
Dominion Voting Systems is seeking at least $1. 3bn (£950m) of damages from Donald Trump's lawyer Rudy Giuiliani for statements that allegedly damaged its reputation and encouraged death threats against its employees.